Ribavirin - medicine shortage information

Back to CRITICAL Shortages     Back to ALL Shortages

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist. In most cases your doctor and pharmacist will know about the possible substitute medicines to continue your care.

In some cases the Supply Detail section below will provide information about the special arrangements that are in place for your health professional to prescribe or supply a substitute medicine. These may include reference to Special Access Scheme or "Under section 19a"

Product details Supply Impact Dates Further Details
VIEKIRA PAK-RBV paritaprevir/ritonavir/ombitasvir 75/50/12.5mg tabs & dasabuvir (Na) 250mg tabs in blist & ribavirin 600mg tabs bottle, composite pack
AUST R: 234442
Active ingredients:
dasabuvir
ombitasvir
paritaprevir
Ribavirin
Ritonavir

Sponsor:
Abbvie Pty Ltd

Phone:
1800043460

Deletion from market:
31 Jan 2019

Status:
Discontinued

Patient impact:
Low

Reason:
Discontinuation

VIEKIRA PAK-RBV paritaprevir/ritonavir/ombitasvir 75mg/50mg/12.5mg tabs and dasabuvir (Na) 250mg tabs and ribavirin 200mg tabs, bottles composite pack
AUST R: 224637
Active ingredients:
dasabuvir sodium monohydrate
ombitasvir
paritaprevir
Ribavirin
Ritonavir

Sponsor:
Abbvie Pty Ltd

Phone:
1800043460

Deletion from market:
31 Jan 2019

Status:
Discontinued

Patient impact:
Medium

Reason:
Discontinuation